ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,680, issued on July 22, was assigned to KIORA PHARMACEUTICALS GmbH (Vienna).
"Compounds for treating ophthalmic diseases and disorders" was invented by Stefan Sperl (Vienna) and Franz Obermayr (Vienna).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates generally to the field of ocular therapeutics and the development thereof for use in humans or animals. More particularly, it relates to DHODH inhibitor compounds and their use for the treatment of ophthalmic diseases and disorders. The invention also relates to the local administration of such ophthalmic compositions, and in particular to their intravitreal administration. Th...